FOLFOX versus 5FU SOC in a neoadjuvant setting for patients with locally advanced Rectal Cancer who will be having an anterior resection.
Inclusion critieria includes but is not limited to: Particpants can be stages T2N1, T3N0 or T3N1 and plan on a curative intent surgical resection. They must be a candidate for sphincter-sparing surgical resection.
Exclusions include but are not limited to: stage T4 disease, prior pelvic radiation, symptomatic bowel obstruction or tumor being adjacent to the mesorectal fascia.
“I have an aggressive type of cancer and it was time to take drastic measures…When I heard about the trial from Dr. Hodge, I felt privileged to have this type of care and the chance to help others who may be in my shoes one day.”